(NASDAQ: IMV) Imv's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 5.96%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 21.89%.
Imv's earnings in 2023 is -$29,999,270.On average, 4 Wall Street analysts forecast IMV's earnings for 2023 to be -$3,288,842, with the lowest IMV earnings forecast at -$5,015,485, and the highest IMV earnings forecast at -$2,219,969. On average, 2 Wall Street analysts forecast IMV's earnings for 2024 to be -$2,055,527, with the lowest IMV earnings forecast at -$2,137,748, and the highest IMV earnings forecast at -$2,055,527.
In 2025, IMV is forecast to generate -$1,479,979 in earnings, with the lowest earnings forecast at -$1,479,979 and the highest earnings forecast at -$1,397,758.